Company Snapshot


Change Company Name
 
Aarti Drugs Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524348
NSE Symbol
AARTIDRUGS
P/E
24.52
ISIN Demat
INE767A01016
Div & Yield %
0.39
EPS
20.7
Book Value
165.78
Market Cap (Rs Cr.)
4,632.41
Face Value
10
Stock Price Details
Last Price (₹) 509.00
Change -1.90 (-0.37%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 505.05 - 527.85
52-Week Range 318.60 - 527.85
Beta (1 Year) 0.66
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE HC, BSE SmallCap
Corporate Announcements
Aarti Drugs consolidated net profit rises 83.17% in the September 2026 quarter
Aarti Drugs to conduct board meeting
Aarti Drugs to conduct AGM
Aarti Drugs to hold board meeting
Aarti Drugs consolidated net profit declines 6.94% in the June 2026 quarter
Aarti Drugs schedules board meeting
Corporate Details
Incorporation Year : 1984
Chairman : Chandrakant V. Gogri
Ownership Group : Aarti Group
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Bulk Drugs
Registered Office :

Aarti Drugs Ltd
Plot No N-198 MIDC Tarapur,
Pamtembhi Village Palghar Tal,
Thane,
Maharashtra - 401506,
Phone : 91-22-24072249,
Fax : 91-22-24073462/24070144
E-Mail : investorrelations@aartidrugs.com
URL : http://www.aartidrugs.com
Investor Returns
Period Date Price(₹) Returns (%)
1Week 06-Nov-2026 446.55 +13.66
1Month 13-Oct-2026 410.40 +23.67
3Month 13-Aug-2026 427.30 +18.78
6Month 13-May-2026 367.00 +38.30
1Year 13-Nov-2025 468.95 +8.23
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
DSP Small Cap Fund 1.37 277.99
ICICI Pru Healthcare Fund 1.00 71.04
DSP Healthcare Fund 1.00 37.09
Motilal Oswal BSE Healthcare.. 0.10 0.04
Bandhan BSE Healthcare Index.. 0.10 0.02
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs
Company Last Price(₹) Change(%) 52Week High(₹) 52Week Low(₹) Market Cap(₹)
Divis Laboratories Ltd 11,489.65 +0.35 11,818.00 5,648.00 305,014.11
Acutaas Chemicals Ltd 4,042.95 +1.21 4,132.75 1,571.20 33,100.09
Neuland Laboratories Ltd 21,081.70 +0.79 24,235.05 11,500.00 27,047.59
Jubilant Pharmova Ltd 965.10 -1.74 1,174.90 783.75 15,374.04
Gujarat Themis Biosyn Ltd 389.25 +0.31 469.90 225.75 5,066.15

Mail Us

Exclusive E-mail Id for redressal of investor grievances

jyotiinvestorgrievance@rediffmail.com
BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com
ATTENTION INVESTORS:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.      |      " KYC is one time excercise while dealing in securities markets-once KYC is done through a SEBI registered intermediary (broker,DP,Mutual Fund etc),you need not undergo the same process again when you approach another intermediary."      |      "Contents which are exclusively for Non-Broking Products/Services, Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."      |      “The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us. ”      |      "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." .......... Issued in the interest of investors"
Company Name Logo

Address

B- 78, 3rd Floor, Defence Colony
New Delhi – 110 024

RISK DISCLOSURES ON DERIVATIVES

Attention Investors

  • Stock Brokers can accept securities as margin only by pledge.
  • Update your mobile number & email Id with your Stock Broker/Depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Precautions for clients dealing in Options

  • Do not Share your trading credentials – login id & passwords including OTP’s.
  • Do not Trade in leveraged products like options without proper understanding, which could lead to losses.
  • Do not Write/ sell options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Do not Deals in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  • Do not Trade in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

NSE SEBI CM INZ000017939 | NSE SEBI F&O INZ000017939 | BSE SEBI CM INZ000017939 | NSDL : IN-DP-443-2019 | CDSL: IN-DP-443-2019 | NCDEX SEBI INZ000017939 | MCX SEBI INZ000017939

@2023 Jyoti Broking Pvt. Ltd. All rights reserved

Designed, Developed, Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)